Delimiting MOGAD as a disease entity using translational imaging

Delimiting MOGAD as a disease entity using translational imaging

The first formal consensus diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) were recently proposed. Yet, the distinction of MOGAD-defining characteristics from characteristics of its important differential diagnoses such as multiple sclerosis (MS) and a...

Full description

Bibliographic Details
Main Authors: Frederike Cosima Oertel, Maria Hastermann, Friedemann Paul
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Neurology
Subjects:
myelin oligodendrocyte glycoprotein associated disease
imaging
translational research
EAE
animal models
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1216477/full

Similar Items

Similar Items